Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Wednesday morning. The firm issued a sell rating on the stock. A number of other brokerages also recently issued reports on ONCT. HC Wainwright restated a buy rating and set a $40.00 price objective on shares of […]

Related Keywords

,Virtu Financial ,Oncternal Therapeutics Inc ,Mirabella Financial Services ,Goldman Sachs Group Inc ,Renaissance Technologies ,Prudential Financial Inc ,Oncternal Therapeutics Company Profile ,Oncternal Therapeutics ,Free Report ,Capital Management ,Get Free Report ,Sachs Group ,Financial Services ,Orphan Receptor ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,